Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold

Dora Berman-Weinberg, J. J. O'Neil, L. C K Coffey, P. C J Chaffanjon, N. M. Kenyon, Phillip Ruiz, A. Pileggi, Camillo Ricordi, Norma S Kenyon

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The aim of this study was to test whether an omental pouch can be used as an alternative site for islet implantation in diabetic monkeys. Here we report the successful engraftment of islets in diabetic cynomolgus monkeys when loaded on a synthetic biodegradable scaffold and placed in an omental pouch. One autologous and five allogeneic diabetic monkey transplants under the cover of steroid-free immune suppression (SFIS) were undertaken. Fasting blood glucose (FBG) and C-peptide (CP), exogenous insulin requirements (EIR), intravenous glucose tolerance test (IVGTT), A1C and histopathology were used to assess islet engraftment and survival. All animals achieved CP levels > 1.0 ng/mL following transplant, a 66-92% posttransplant decrease in EIR and reduced A1C. Following graft removal, CP became negative and histopathological analysis of the explanted grafts demonstrated well-granulated and well-vascularized, insulin-positive islets, surrounded by T-cell subsets and macrophages. Compared to intrahepatic allogeneic islet transplants (n = 20), there was a delayed engraftment for omental pouch recipients but similar levels of CP production were ultimately achieved, with a broad range of IEQ/kg transplanted in both sites. Our results suggest this extrahepatic transplantation site has potential as an alternative site for clinical islet cell transplantation.

Original languageEnglish
Pages (from-to)91-104
Number of pages14
JournalAmerican Journal of Transplantation
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Primates
C-Peptide
Transplants
Insulin
Haplorhini
Islets of Langerhans Transplantation
Macaca fascicularis
Cell Transplantation
T-Lymphocyte Subsets
Glucose Tolerance Test
Islets of Langerhans
Blood Glucose
Fasting
Transplantation
Macrophages
Steroids

Keywords

  • Alternative sites
  • Graft survival
  • Islet engraftment
  • Islet transplantation
  • Scaffold

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. / Berman-Weinberg, Dora; O'Neil, J. J.; Coffey, L. C K; Chaffanjon, P. C J; Kenyon, N. M.; Ruiz, Phillip; Pileggi, A.; Ricordi, Camillo; Kenyon, Norma S.

In: American Journal of Transplantation, Vol. 9, No. 1, 01.01.2009, p. 91-104.

Research output: Contribution to journalArticle

@article{d41467a683e145ff9f8321534733a42d,
title = "Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold",
abstract = "The aim of this study was to test whether an omental pouch can be used as an alternative site for islet implantation in diabetic monkeys. Here we report the successful engraftment of islets in diabetic cynomolgus monkeys when loaded on a synthetic biodegradable scaffold and placed in an omental pouch. One autologous and five allogeneic diabetic monkey transplants under the cover of steroid-free immune suppression (SFIS) were undertaken. Fasting blood glucose (FBG) and C-peptide (CP), exogenous insulin requirements (EIR), intravenous glucose tolerance test (IVGTT), A1C and histopathology were used to assess islet engraftment and survival. All animals achieved CP levels > 1.0 ng/mL following transplant, a 66-92{\%} posttransplant decrease in EIR and reduced A1C. Following graft removal, CP became negative and histopathological analysis of the explanted grafts demonstrated well-granulated and well-vascularized, insulin-positive islets, surrounded by T-cell subsets and macrophages. Compared to intrahepatic allogeneic islet transplants (n = 20), there was a delayed engraftment for omental pouch recipients but similar levels of CP production were ultimately achieved, with a broad range of IEQ/kg transplanted in both sites. Our results suggest this extrahepatic transplantation site has potential as an alternative site for clinical islet cell transplantation.",
keywords = "Alternative sites, Graft survival, Islet engraftment, Islet transplantation, Scaffold",
author = "Dora Berman-Weinberg and O'Neil, {J. J.} and Coffey, {L. C K} and Chaffanjon, {P. C J} and Kenyon, {N. M.} and Phillip Ruiz and A. Pileggi and Camillo Ricordi and Kenyon, {Norma S}",
year = "2009",
month = "1",
day = "1",
doi = "10.1111/j.1600-6143.2008.02489.x",
language = "English",
volume = "9",
pages = "91--104",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold

AU - Berman-Weinberg, Dora

AU - O'Neil, J. J.

AU - Coffey, L. C K

AU - Chaffanjon, P. C J

AU - Kenyon, N. M.

AU - Ruiz, Phillip

AU - Pileggi, A.

AU - Ricordi, Camillo

AU - Kenyon, Norma S

PY - 2009/1/1

Y1 - 2009/1/1

N2 - The aim of this study was to test whether an omental pouch can be used as an alternative site for islet implantation in diabetic monkeys. Here we report the successful engraftment of islets in diabetic cynomolgus monkeys when loaded on a synthetic biodegradable scaffold and placed in an omental pouch. One autologous and five allogeneic diabetic monkey transplants under the cover of steroid-free immune suppression (SFIS) were undertaken. Fasting blood glucose (FBG) and C-peptide (CP), exogenous insulin requirements (EIR), intravenous glucose tolerance test (IVGTT), A1C and histopathology were used to assess islet engraftment and survival. All animals achieved CP levels > 1.0 ng/mL following transplant, a 66-92% posttransplant decrease in EIR and reduced A1C. Following graft removal, CP became negative and histopathological analysis of the explanted grafts demonstrated well-granulated and well-vascularized, insulin-positive islets, surrounded by T-cell subsets and macrophages. Compared to intrahepatic allogeneic islet transplants (n = 20), there was a delayed engraftment for omental pouch recipients but similar levels of CP production were ultimately achieved, with a broad range of IEQ/kg transplanted in both sites. Our results suggest this extrahepatic transplantation site has potential as an alternative site for clinical islet cell transplantation.

AB - The aim of this study was to test whether an omental pouch can be used as an alternative site for islet implantation in diabetic monkeys. Here we report the successful engraftment of islets in diabetic cynomolgus monkeys when loaded on a synthetic biodegradable scaffold and placed in an omental pouch. One autologous and five allogeneic diabetic monkey transplants under the cover of steroid-free immune suppression (SFIS) were undertaken. Fasting blood glucose (FBG) and C-peptide (CP), exogenous insulin requirements (EIR), intravenous glucose tolerance test (IVGTT), A1C and histopathology were used to assess islet engraftment and survival. All animals achieved CP levels > 1.0 ng/mL following transplant, a 66-92% posttransplant decrease in EIR and reduced A1C. Following graft removal, CP became negative and histopathological analysis of the explanted grafts demonstrated well-granulated and well-vascularized, insulin-positive islets, surrounded by T-cell subsets and macrophages. Compared to intrahepatic allogeneic islet transplants (n = 20), there was a delayed engraftment for omental pouch recipients but similar levels of CP production were ultimately achieved, with a broad range of IEQ/kg transplanted in both sites. Our results suggest this extrahepatic transplantation site has potential as an alternative site for clinical islet cell transplantation.

KW - Alternative sites

KW - Graft survival

KW - Islet engraftment

KW - Islet transplantation

KW - Scaffold

UR - http://www.scopus.com/inward/record.url?scp=58049221199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58049221199&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2008.02489.x

DO - 10.1111/j.1600-6143.2008.02489.x

M3 - Article

C2 - 19133931

AN - SCOPUS:58049221199

VL - 9

SP - 91

EP - 104

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 1

ER -